For research use only. Not for therapeutic Use.
Vicasinabin(Cat No.:I045089)is an investigational synthetic cannabinoid receptor type 2 (CB2) agonist developed for the treatment of inflammatory and neuropathic pain. By selectively targeting CB2 receptors—primarily expressed in immune cells and peripheral tissues—Vicasinabin offers anti-inflammatory and analgesic effects without the psychoactive properties associated with CB1 activation. It modulates cytokine release and immune cell activity, making it a promising candidate for conditions like arthritis, multiple sclerosis, and chronic pain syndromes. Vicasinabin is under preclinical evaluation and is supplied for research focused on cannabinoid-based therapeutics and immune-mediated disorders.
CAS Number | 1433361-02-4 |
Synonyms | (3S)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol |
Molecular Formula | C15H22N10O |
Purity | ≥95% |
IUPAC Name | (3S)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol |
InChI | InChI=1S/C15H22N10O/c1-15(2,3)14-16-12(24-6-5-9(26)7-24)11-13(17-14)25(21-19-11)8-10-18-20-22-23(10)4/h9,26H,5-8H2,1-4H3/t9-/m0/s1 |
InChIKey | MAYZWDRUFKUGGP-VIFPVBQESA-N |
SMILES | CC(C)(C)C1=NC2=C(C(=N1)N3CC[C@@H](C3)O)N=NN2CC4=NN=NN4C |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |